Literature DB >> 33152482

Post-loading of proangiogenic growth factors in PLGA microspheres.

Karina C Scheiner1, Roel F Maas-Bakker1, Mies J van Steenbergen1, Steven P Schwendeman2, Wim E Hennink1, Robbert J Kok3.   

Abstract

Active self-encapsulation (ASE) is a recently developed post-loading method based on absorption of (positively charged) proteins in microporous PLGA microspheres loaded with negatively charged polysaccharides (trapping agents). The aim of this study was to investigate ASE for simultaneous loading and controlled release of multiple growth factors. For this purpose, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and insulin-like growth factor (IGF) were loaded in microspheres containing high molecular weight dextran sulfate (HDS) as trapping agent; loading was performed in a concentrated growth factor solution of low ionic strength and of pH 5 under conditions at which the proteins are positively charged. Subsequent pore closure was induced by incubation of the growth factor-loaded microspheres at 42.5 °C, i.e. above the Tg of (hydrated) PLGA (~30 °C). A 1:1:1 combination of VEGF, FGF and IGF was loaded with high loading (4.3%) and loading efficiency (91%). The in vitro release kinetics and bioactivity of loaded growth factors were studied for 4 weeks using ELISA and an endothelial cell proliferation assay, respectively. While IGF was released quickly, VEGF and FGF were continuously released for 4 weeks in their bioactive form, whereby a growth factor combination had a synergistic angiogenic effect. Therefore, ASE is a suitable method for co-loading growth factors which can provide sustained release profiles of bioactive growth factors, which is attractive for vascularization of biomaterial implants.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Controlled release; Growth factors; Implants; PLGA; Post-loading; Therapeutic angiogenesis

Year:  2020        PMID: 33152482     DOI: 10.1016/j.ejpb.2020.10.022

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Engineering microparticles based on solidified stem cell secretome with an augmented pro-angiogenic factor portfolio for therapeutic angiogenesis.

Authors:  Thomas Später; Marisa Assunção; Kwok Keung Lit; Guidong Gong; Xiaoling Wang; Yi-Yun Chen; Ying Rao; Yucong Li; Chi Him Kendrick Yiu; Matthias W Laschke; Michael D Menger; Dan Wang; Rocky S Tuan; Kay-Hooi Khoo; Michael Raghunath; Junling Guo; Anna Blocki
Journal:  Bioact Mater       Date:  2022-04-02

2.  Bacteriostatic and Cytotoxic Properties of Composite Material Based on ZnO Nanoparticles in PLGA Obtained by Low Temperature Method.

Authors:  Dmitriy E Burmistrov; Alexander V Simakin; Veronika V Smirnova; Oleg V Uvarov; Petr I Ivashkin; Roman N Kucherov; Vladimir E Ivanov; Vadim I Bruskov; Mihail A Sevostyanov; Alexander S Baikin; Valery A Kozlov; Maksim B Rebezov; Anastasia A Semenova; Andrey B Lisitsyn; Maria V Vedunova; Sergey V Gudkov
Journal:  Polymers (Basel)       Date:  2021-12-23       Impact factor: 4.329

Review 3.  Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.

Authors:  Yabing Hua; Yuhuai Su; Hui Zhang; Nan Liu; Zengming Wang; Xiang Gao; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.